InvestorsHub Logo
Followers 20
Posts 1931
Boards Moderated 0
Alias Born 03/21/2010

Re: None

Thursday, 11/05/2020 10:13:51 AM

Thursday, November 05, 2020 10:13:51 AM

Post# of 427530
"Reaffirmed clinical trial results from study of VASCEPA in China are expected by year end 2020: Assuming positive results from this study conducted by Amarin’s commercial partner for VASCEPA in China, regulatory submission in China could follow promptly thereafter."

JT getting aggressive here. But then again, promptly in his world could mean before the end of 2021. I've never seen anyone in business with such an incredible disregard for the concept of urgency.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News